ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1539

Digital Ischemia, a Rare Manifestation in Anti-neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV)

Adil Vural1, Chao Zhang2 and Kinanah Yaseen1, 1Cleveland Clinic, Cleveland, OH, 2Cleveland Clinic Foundation, Cleveland, OH

Meeting: ACR Convergence 2023

Keywords: ANCA associated vasculitis, Comorbidity, Peripheral Vascular Disease, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1534–1553) Vasculitis – ANCA-Associated Poster II: Epidemiology, Outcomes, & Classification

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Digital ischemia is a rare, yet severe manifestation observed in AAV. Despite gangrene being a major criterion in the Birmingham Vasculitis Activity Score, this clinical entity is not well described in the literature. We aimed to investigate digital ischemia in AAV.

Methods: This retrospective case series analyzed adult patients with a confirmed diagnosis of AAV and digital ischemia/gangrene, as determined by vasculitis specialists at Cleveland Clinic. Patients without digital ischemia, those diagnosed with a vasculitis other than AAV, and those with digital ischemia related to other causes were excluded from the study. Data collection spanned from January 2002 to January 2023 obtained by chart review.

Results: Twelve patients met the inclusion criteria. The mean age at diagnosis was 52.6 years (SD=18.2), with a male-to-female ratio of 3:1. 33.3% of the patients were active smokers. All patients were diagnosed with granulomatosis with polyangiitis (GPA) and the majority (75%) tested positive for c-ANCA antibodies and PR3 antigen. Other organ involvements at the time of digital ischemia presentation were pulmonary (75%), followed by upper respiratory tract (66.7%), and renal (66.7%) (Table 1).

In terms of digital ischemia, 5 patients (41.6%) had isolated upper extremity involvement, 2 patients (16.6%) had isolated lower extremity involvement, and 5 patients (41.6%) had in both upper and lower extremities. The mean count of involved digits was 4.5 (SD=2.97). Doppler US was the most frequently employed vascular diagnostic modality (83.3%). The most frequently involved vessels were the digital arteries (33.3%). 75% of patients presented with digital ischemia leading to a new diagnosis of GPA, while 3 patients (25%) developed digital ischemia during a disease flare (Table 2).

Treatment strategies for induction therapy were cyclophosphamide CYC in 33.3%, and rituximab (RTX) in 50.0% of patients respectively in addition to glucocorticoids. Maintenance therapy predominantly consisted of RTX (41.7%). Following diagnosis, 66.7% of patients received anticoagulation therapy, primarily with warfarin (62.5%), and 41.7% received anti-platelet therapy (Table 1).

At 6 months, remission was achieved in 10 patients (Figure 1). Surgical amputation was required in 58.3% of patients, 25% experienced autoamputation, while only 25% of patients had complete healing of all digital gangrene. Among the 3 patients who had complete healing; 2 patients were on anticoagulation after developing digital ischemia for a treatment of deep venous thrombosis.

Conclusion: This study provides insights into AAV-associated digital ischemia which is a rare manifestation of this disease. When present, digital ischemia can be the initial presenting feature leading to GPA diagnosis and generally it occurs in conjunction with other organ involvement. Therefore, GPA should be on the differential diagnosis for patients presenting with digital ischemia. Despite most patients achieving remission, a high degree of morbidity occurred with surgical and/or autoamputation of single or multiple digits. Further research is needed to evaluate the role of adjunct treatments such as anticoagulation and anti-platelet for this rare manifestation.

Supporting image 1

Table 1. Baseline characteristics.

Supporting image 2

Table 2. Summary of digital ischemia features.

Supporting image 3

Figure 1. Outcomes of digital ischemia in ANCA associated vasculitis.


Disclosures: A. Vural: None; C. Zhang: None; K. Yaseen: None.

To cite this abstract in AMA style:

Vural A, Zhang C, Yaseen K. Digital Ischemia, a Rare Manifestation in Anti-neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV) [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/digital-ischemia-a-rare-manifestation-in-anti-neutrophil-cytoplasmic-antibody-anca-associated-vasculitis-aav/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/digital-ischemia-a-rare-manifestation-in-anti-neutrophil-cytoplasmic-antibody-anca-associated-vasculitis-aav/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology